Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
For full access to this article login to GEN Select now.
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
- Capturing and identifying circulating DNA could hold the key to rapid, minimally invasive, disease diagnostics—ultimately improving clinical decision making and outcomes. [oonal / Getty Images]
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.